Search filters

List of works by Christopher A Eide

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

scientific article

Activating alleles of JAK3 in acute megakaryoblastic leukemia

scientific article published on July 2006

Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia

scientific article published on 16 January 2014

BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia

scientific article published on 14 August 2014

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms

scientific article published in Nature Communications

Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.

scientific article

Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

scientific article published on 31 July 2019

Growth arrest of BCR-ABL positive cells with a sequence-specific polyamide-chlorambucil conjugate

scientific article

High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia

scientific article published on 5 February 2008

High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients

scientific article published on 15 December 2008

HitWalker: variant prioritization for personalized functional cancer genomics

scientific article

Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML

scientific article

The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile

scientific article published on 19 April 2011

Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis

scientific article published on 10 April 2013